Logo image of GS2C.DE

GAMESTOP CORP-CLASS A (GS2C.DE) Stock Fundamental Analysis

FRA:GS2C - Deutsche Boerse Ag - US36467W1099 - Common Stock - Currency: EUR

25.15  -0.41 (-1.58%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to GS2C. GS2C was compared to 51 industry peers in the Specialty Retail industry. While GS2C has a great health rating, there are worries on its profitability. GS2C has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

GS2C had positive earnings in the past year.
GS2C had a negative operating cash flow in the past year.
GS2C had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GS2C reported negative operating cash flow in multiple years.
GS2C.DE Yearly Net Income VS EBIT VS OCF VS FCFGS2C.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M -600M

1.2 Ratios

GS2C's Return On Assets of 1.01% is in line compared to the rest of the industry. GS2C outperforms 57.45% of its industry peers.
GS2C has a Return On Equity (1.31%) which is in line with its industry peers.
Industry RankSector Rank
ROA 1.01%
ROE 1.31%
ROIC N/A
ROA(3y)-6.9%
ROA(5y)-9.22%
ROE(3y)-15.66%
ROE(5y)-34.66%
ROIC(3y)N/A
ROIC(5y)N/A
GS2C.DE Yearly ROA, ROE, ROICGS2C.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

GS2C's Profit Margin of 1.45% is fine compared to the rest of the industry. GS2C outperforms 61.70% of its industry peers.
With a Gross Margin value of 26.99%, GS2C is not doing good in the industry: 70.21% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of GS2C has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 1.45%
GM 26.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y-2.5%
GS2C.DE Yearly Profit, Operating, Gross MarginsGS2C.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

GS2C does not have a ROIC to compare to the WACC, probably because it is not profitable.
GS2C has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, GS2C has less shares outstanding
The debt/assets ratio for GS2C has been reduced compared to a year ago.
GS2C.DE Yearly Shares OutstandingGS2C.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
GS2C.DE Yearly Total Debt VS Total AssetsGS2C.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 6.35 indicates that GS2C is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.35, GS2C belongs to the top of the industry, outperforming 93.62% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that GS2C is not too dependend on debt financing.
GS2C has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. GS2C outperforms 95.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.35
ROIC/WACCN/A
WACC10.13%
GS2C.DE Yearly LT Debt VS Equity VS FCFGS2C.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

GS2C has a Current Ratio of 5.11. This indicates that GS2C is financially healthy and has no problem in meeting its short term obligations.
GS2C has a Current ratio of 5.11. This is amongst the best in the industry. GS2C outperforms 95.74% of its industry peers.
GS2C has a Quick Ratio of 4.36. This indicates that GS2C is financially healthy and has no problem in meeting its short term obligations.
GS2C has a better Quick ratio (4.36) than 95.74% of its industry peers.
Industry RankSector Rank
Current Ratio 5.11
Quick Ratio 4.36
GS2C.DE Yearly Current Assets VS Current LiabilitesGS2C.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

GS2C shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1800.00%, which is quite impressive.
The earnings per share for GS2C have been decreasing by -40.58% on average. This is quite bad
The Revenue for GS2C has decreased by -24.04% in the past year. This is quite bad
Measured over the past years, GS2C shows a decrease in Revenue. The Revenue has been decreasing by -8.64% on average per year.
EPS 1Y (TTM)1800%
EPS 3YN/A
EPS 5Y-40.58%
EPS Q2Q%491.53%
Revenue 1Y (TTM)-24.04%
Revenue growth 3Y1.18%
Revenue growth 5Y-8.64%
Sales Q2Q%-20.22%

3.2 Future

The Earnings Per Share is expected to grow by 37.96% on average over the next years. This is a very strong growth
GS2C is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -14.54% yearly.
EPS Next Y41.4%
EPS Next 2Y-41.42%
EPS Next 3Y37.96%
EPS Next 5YN/A
Revenue Next Year-27.33%
Revenue Next 2Y-17.65%
Revenue Next 3Y-14.54%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GS2C.DE Yearly Revenue VS EstimatesGS2C.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
GS2C.DE Yearly EPS VS EstimatesGS2C.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 157.19, GS2C can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of GS2C is on the same level as its industry peers.
When comparing the Price/Earnings ratio of GS2C to the average of the S&P500 Index (28.47), we can say GS2C is valued expensively.
Industry RankSector Rank
PE 157.19
Fwd PE N/A
GS2C.DE Price Earnings VS Forward Price EarningsGS2C.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GS2C is valued a bit more expensive than the industry average as 74.47% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 495.39
GS2C.DE Per share dataGS2C.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as GS2C's earnings are expected to grow with 37.96% in the coming years.
PEG (NY)3.8
PEG (5Y)N/A
EPS Next 2Y-41.42%
EPS Next 3Y37.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GS2C!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GAMESTOP CORP-CLASS A

FRA:GS2C (2/4/2025, 7:00:00 PM)

25.15

-0.41 (-1.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-10 2024-12-10/amc
Earnings (Next)N/A N/A
Inst Owners22.18%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap11.24B
Analysts40
Price Target9.82 (-60.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)152.6%
Min EPS beat(2)111.65%
Max EPS beat(2)193.55%
EPS beat(4)2
Avg EPS beat(4)61.76%
Min EPS beat(4)-32.01%
Max EPS beat(4)193.55%
EPS beat(8)5
Avg EPS beat(8)78.66%
EPS beat(12)6
Avg EPS beat(12)22.06%
EPS beat(16)7
Avg EPS beat(16)8.13%
Revenue beat(2)0
Avg Revenue beat(2)-7.9%
Min Revenue beat(2)-11.75%
Max Revenue beat(2)-4.05%
Revenue beat(4)0
Avg Revenue beat(4)-10.35%
Min Revenue beat(4)-13.35%
Max Revenue beat(4)-4.05%
Revenue beat(8)2
Avg Revenue beat(8)-7.36%
Revenue beat(12)4
Avg Revenue beat(12)-6.57%
Revenue beat(16)7
Avg Revenue beat(16)-3.92%
PT rev (1m)27.12%
PT rev (3m)32.07%
EPS NQ rev (1m)-5.88%
EPS NQ rev (3m)-38.46%
EPS NY rev (1m)0%
EPS NY rev (3m)333.33%
Revenue NQ rev (1m)-1.45%
Revenue NQ rev (3m)-5.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.22%
Valuation
Industry RankSector Rank
PE 157.19
Fwd PE N/A
P/S 2.68
P/FCF N/A
P/OCF N/A
P/B 2.42
P/tB 2.42
EV/EBITDA 495.39
EPS(TTM)0.16
EY0.64%
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS9.39
BVpS10.4
TBVpS10.4
PEG (NY)3.8
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.01%
ROE 1.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.45%
GM 26.99%
FCFM N/A
ROA(3y)-6.9%
ROA(5y)-9.22%
ROE(3y)-15.66%
ROE(5y)-34.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.27%
GM growth 5Y-2.5%
F-Score5
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.68
Cap/Depr 39.42%
Cap/Sales 0.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.11
Quick Ratio 4.36
Altman-Z 6.35
F-Score5
WACC10.13%
ROIC/WACCN/A
Cap/Depr(3y)77.67%
Cap/Depr(5y)77.79%
Cap/Sales(3y)0.88%
Cap/Sales(5y)1.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1800%
EPS 3YN/A
EPS 5Y-40.58%
EPS Q2Q%491.53%
EPS Next Y41.4%
EPS Next 2Y-41.42%
EPS Next 3Y37.96%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.04%
Revenue growth 3Y1.18%
Revenue growth 5Y-8.64%
Sales Q2Q%-20.22%
Revenue Next Year-27.33%
Revenue Next 2Y-17.65%
Revenue Next 3Y-14.54%
Revenue Next 5YN/A
EBIT growth 1Y38.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year134.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y88.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.89%
OCF growth 3YN/A
OCF growth 5YN/A